Barclays Maintains an 'Overweight' on Allscripts-Misys Healthcare (MDRX); Tone Into 4Q: Focus on Eclipsys Growth, Progress on Merger Integration

Go back to Barclays Maintains an 'Overweight' on Allscripts-Misys Healthcare (MDRX); Tone Into 4Q: Focus on Eclipsys Growth, Progress on Merger Integration